DK417289A - Beta-carboliner og deres bio-isosteriske benzofuran- og benzothiophenanaloge - Google Patents

Beta-carboliner og deres bio-isosteriske benzofuran- og benzothiophenanaloge

Info

Publication number
DK417289A
DK417289A DK417289A DK417289A DK417289A DK 417289 A DK417289 A DK 417289A DK 417289 A DK417289 A DK 417289A DK 417289 A DK417289 A DK 417289A DK 417289 A DK417289 A DK 417289A
Authority
DK
Denmark
Prior art keywords
benzothiophenanalogue
isosteric
benzofuran
bio
beta carbolines
Prior art date
Application number
DK417289A
Other languages
English (en)
Other versions
DK417289D0 (da
Inventor
Antonius Hulkenberg
Ineke Van Wijngaarden
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of DK417289D0 publication Critical patent/DK417289D0/da
Publication of DK417289A publication Critical patent/DK417289A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D515/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK417289A 1988-08-29 1989-08-24 Beta-carboliner og deres bio-isosteriske benzofuran- og benzothiophenanaloge DK417289A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8802123 1988-08-29

Publications (2)

Publication Number Publication Date
DK417289D0 DK417289D0 (da) 1989-08-24
DK417289A true DK417289A (da) 1990-03-01

Family

ID=19852815

Family Applications (1)

Application Number Title Priority Date Filing Date
DK417289A DK417289A (da) 1988-08-29 1989-08-24 Beta-carboliner og deres bio-isosteriske benzofuran- og benzothiophenanaloge

Country Status (9)

Country Link
US (1) US5095020A (da)
EP (1) EP0357122A3 (da)
JP (1) JPH02111772A (da)
AU (1) AU625068B2 (da)
CA (1) CA1337200C (da)
DK (1) DK417289A (da)
IL (1) IL91452A (da)
NZ (1) NZ230431A (da)
ZA (1) ZA896473B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3855147D1 (de) * 1987-07-20 1996-05-02 Duphar Int Res 8,9-Anellierte 1,2,3,4-Tetrahydro-beta-carbolin-Derivate
EP0347980A1 (en) * 1988-06-20 1989-12-27 Duphar International Research B.V 8,9-Annelated beta-carbolines and 8,9-anelated-3,4-dihydro-beta-carbolines
EP0380155A1 (en) * 1989-01-19 1990-08-01 Duphar International Research B.V 8,9-Annelated-1,2,3,4-tetrahydro-beta-carboline derivatives
US5622960A (en) * 1992-04-14 1997-04-22 The United States Of America As Represented By The Department Of Health And Human Services Topoisomerase II inhibitors and therapeutic uses therefor
GB9514465D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
US6143746A (en) * 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
GB9401090D0 (en) * 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
GB9514464D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
GB9514473D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
BR9709230A (pt) * 1996-05-10 1999-08-10 Icos Corp Composto
DE19744257B4 (de) * 1997-10-07 2004-04-15 Zentaris Gmbh Beta-Carboline und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen
DE60121461T2 (de) * 2000-10-03 2007-02-08 Lilly Icos Llc, Wilmington Kondensierte pyridoindolderivate
TWI329111B (en) 2002-05-24 2010-08-21 X Ceptor Therapeutics Inc Azepinoindole and pyridoindole derivatives as pharmaceutical agents
US7872133B2 (en) * 2003-06-23 2011-01-18 Ono Pharmaceutical Co., Ltd. Tricyclic heterocycle compound
CN1910183A (zh) * 2004-01-23 2007-02-07 希龙公司 四氢咔啉化合物作为抗癌药
UA92317C2 (ru) * 2004-03-15 2010-10-25 Пи-Ти-Си ТЕРАПЬЮТИКС, ИНК. Производные карболина, пригодные для ингибирования развития кровеносных сосудов
US7767689B2 (en) * 2004-03-15 2010-08-03 Ptc Therapeutics, Inc. Carboline derivatives useful in the treatment of cancer
US8076353B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Inhibition of VEGF translation
US8076352B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Administration of carboline derivatives useful in the treatment of cancer and other diseases
ATE486878T1 (de) 2004-08-18 2010-11-15 4Sc Ag Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin
EP1829874B1 (en) * 2004-12-22 2014-02-12 Ono Pharmaceutical Co., Ltd. Tricyclic compound and use thereof
WO2006079645A1 (en) * 2005-01-27 2006-08-03 Nycomed Gmbh Novel indolopyridines , benzofuranopyridines and benzothienopyridines
JP2008528551A (ja) * 2005-01-28 2008-07-31 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング インドロピリジン、ベンゾフラノピリジン及びベンゾチエノピリジン
KR101415354B1 (ko) 2006-02-22 2014-07-04 4에스체 악티엔게젤샤프트 Ｅｇ5 키네신 조절제로서의 인돌로피리딘
FR2914924A1 (fr) * 2007-04-13 2008-10-17 Fourtillan Snc Derives de 4,5,11,11a-tetrahydro-1h,6h-oxazolo[3',4': 1,6] pyrido[3,4-b]indol-3-one et leur utilisation en therapeutique.
WO2010138685A1 (en) 2009-05-27 2010-12-02 Ptc Therapeutics, Inc. Methods for treating prostate conditions
CA2763479A1 (en) 2009-05-27 2010-12-02 Ptc Therapeutics, Inc. Processes for the preparation of substituted tetrahydro beta-carbolines
WO2010138652A1 (en) 2009-05-27 2010-12-02 Ptc Therapeutics, Inc. Methods for treating kaposi sarcoma
MX373926B (es) 2009-05-27 2020-07-10 Ptc Therapeutics Inc Metodos para tratar cancer y estados no neoplasicos.
CA2803697A1 (en) 2010-06-25 2011-12-29 Facultes Universitaires Notre Dame De La Paix Beta carboline derivatives useful in the treatment of proliferative disorders
JP5649170B2 (ja) * 2010-11-26 2015-01-07 国立大学法人 千葉大学 テトラヒドロ−β−カルボリン誘導体及びその製造方法
CN103450199B (zh) * 2012-06-01 2015-09-09 首都医科大学 茶氨酸修饰的咔啉酰氨基酸苄酯、其制备、抗肿瘤活性和应用
EP3664803A4 (en) 2017-08-01 2021-05-05 PTC Therapeutics, Inc. DHODH INHIBITOR FOR USE IN THE TREATMENT OF HEMATOLOGICAL CANCERS
US10947253B2 (en) 2019-08-05 2021-03-16 Ankh Life Sciences Limited Fused polycyclic dimers
US12129265B2 (en) 2020-07-21 2024-10-29 Ankh Life Sciences Limited Therapeutic agents and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES273769A1 (es) * 1961-01-18 1962-06-01 Geigy Ag J R Procedimiento para la preparaciën de nuevos derivados de amidas de acido beta-carbolin-carboxilico
FR1310971A (fr) * 1962-01-17 1962-11-30 Geigy Ag J R Nouveaux dérivés de la beta-carboline et leur préparation
FR1310970A (fr) * 1962-01-17 1962-11-30 Geigy Ag J R Nouveaux dérivés de la beta-carboline à substituants basiques et leur préparation
US3644384A (en) * 1969-06-09 1972-02-22 Sterling Drug Inc Certain 2-(alpha-haloacetyl) - 1 2 3 4-tetrahydro - 9h - pyrido(3 4-b)indole-3-carboxylates and derivatives
US4336260A (en) * 1977-12-08 1982-06-22 The Dow Chemical Company Method and compositions using 1-aryl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid for treating depression
PH25651A (en) * 1986-05-21 1991-08-21 Duphar Int Res New di, tetrahydroisoquinoline derivatives
WO1988000826A1 (en) * 1986-08-05 1988-02-11 Harbor Branch Oceanographic Institution, Inc. Antitumor compositions and their methods of use
DE3855147D1 (de) * 1987-07-20 1996-05-02 Duphar Int Res 8,9-Anellierte 1,2,3,4-Tetrahydro-beta-carbolin-Derivate
DK686688A (da) * 1987-12-14 1989-06-15 Duphar Int Res 8,9-annelerede beta-carboliner, deres fremstilling og laegemidler indeholdende forbindelserne
EP0347980A1 (en) * 1988-06-20 1989-12-27 Duphar International Research B.V 8,9-Annelated beta-carbolines and 8,9-anelated-3,4-dihydro-beta-carbolines
US4962163A (en) * 1989-01-17 1990-10-09 The Dow Chemical Company Vinyl ester resins containing mesogenic/rigid rodlike moieties

Also Published As

Publication number Publication date
AU4083089A (en) 1990-05-10
DK417289D0 (da) 1989-08-24
ZA896473B (en) 1990-09-26
NZ230431A (en) 1992-03-26
JPH02111772A (ja) 1990-04-24
EP0357122A3 (en) 1991-10-23
IL91452A0 (en) 1990-04-29
AU625068B2 (en) 1992-07-02
IL91452A (en) 1994-05-30
EP0357122A2 (en) 1990-03-07
US5095020A (en) 1992-03-10
CA1337200C (en) 1995-10-03

Similar Documents

Publication Publication Date Title
DK417289D0 (da) Beta-carboliner og deres bio-isosteriske benzofuran- og benzothiophenanaloge
NO881660D0 (no) Hepariner og femgangsmaate for deres fremstilling.
NO882390D0 (no) (ih-azol-1-ylmetyl)substituerte benzotriazolderivater og deres fremstilling.
DK317588A (da) 2-anilino-pyrimidin-derivat samt deres fremstilling og anvendelse
DK421488D0 (da) Pyridiniumderivater og deres anvendelse
DK595388D0 (da) Benzopyranderivater, deres fremstilling og anvendelse
NO895030D0 (no) 2-imino-benzotiazolinderivater og deres fremstilling.
DK45188D0 (da) Substituerede aminderivater og deres anvendelse
DK193088D0 (da) 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse
DK293888D0 (da) Fenolderivater og deres fremstilling og anvendelse
DK278188D0 (da) Thiazolidin-4-on-derivater, deres fremstilling og anvendelse
DK294989A (da) 8,9-annelerede beta-carboliner og 8,9-annelerede 3,4-dihydro-beta-carboliner
DK189488A (da) Imidazothiadiazinderivater, deres fremstilling og anvendelse
DK236585D0 (da) Acylerede hexosederivater samt deres fremstilling og anvendelse
DK634089A (da) Polyhydroxybenzyloxypropanolaminer og deres anvendelse
DK501989D0 (da) Mikrobiocidt praeparat og dettes fremstilling
DK223288A (da) Benzensulfornamid-derivater, deres fremstilling og anvendelse
DK412188D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK422685A (da) Benzazolderivater samt deres fremstilling og anvendelse
DK361388D0 (da) Cephemderivater, deres fremstilling og anvendelse
DK153285D0 (da) Benzodioxolderivater samt deres fremstilling og anvendelse
DK410089D0 (da) Substituerede phenylalkylthiophener og dens fremstilling
DK613888A (da) Acyllabdan-derivater, deres fremstilling og anvendelse
DK668788A (da) Labdanderivater, deres fremstilling og anvendelse
DK668888D0 (da) Labdan-derivater, deres fremstilling og anvendelse